# Lion Point Capital, LP: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 1643354.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $20.9m
- Positions: 35 (35 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1643354/000101359426000908/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [CUE BIOPHARMA INC (CUE)](/companies/cue.md) | COM | $1.7m | 8.0% | 52,928 |  | New +52,928 |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $1.5m | 7.1% | 4,450 |  | Unchanged |
| [MOONLAKE IMMUNOTHERAPEUTICS (MLTX)](/companies/mltx.md) | CLASS A ORD | $1.3m | 6.3% | 67,500 |  | Unchanged |
| [FENNEC PHARMACEUTICALS INC (FENC)](/companies/fenc.md) | COM | $1.2m | 5.8% | 112,434 |  | Unchanged |
| ROYALTY PHARMA PLC | SHS CLASS A | $1.2m | 5.7% | 21,400 |  | Unchanged |
| [COMPASS PATHWAYS PLC (CMPS)](/companies/cmps.md) | SPONSORED ADS | $1.1m | 5.4% | 80,000 |  | Unchanged |
| [MILESTONE PHARMACEUTICALS IN (MIST)](/companies/mist.md) | COM | $1.1m | 5.3% | 820,000 |  | Unchanged |
| [BENITEC BIOPHARMA INC (BNTC)](/companies/bntc.md) | COM NEW | $829.6k | 4.0% | 62,000 |  | Unchanged |
| [SYNDAX PHARMACEUTICALS INC (SNDX)](/companies/sndx.md) | COM | $787.0k | 3.8% | 36,000 |  | Unchanged |
| BIOHAVEN LTD | COM | $769.3k | 3.7% | 51,700 |  | Unchanged |
| [GERON CORP (GERN)](/companies/gern.md) | COM | $739.8k | 3.5% | 578,000 |  | Unchanged |
| UNIQURE NV | SHS | $677.1k | 3.2% | 14,700 |  | Unchanged |
| [ARDELYX INC (ARDX)](/companies/ardx.md) | COM | $656.1k | 3.1% | 128,650 |  | Unchanged |
| [LANTHEUS HLDGS INC (LNTH)](/companies/lnth.md) | COM | $610.2k | 2.9% | 5,500 |  | Unchanged |
| [DISC MEDICINE INC (IRON)](/companies/iron.md) | COM | $592.4k | 2.8% | 8,100 |  | Unchanged |
| [SAREPTA THERAPEUTICS INC (SRPT)](/companies/srpt.md) | COM | $512.1k | 2.4% | 28,500 |  | Unchanged |
| [HUMACYTE INC (HUMA)](/companies/huma.md) | COM | $507.3k | 2.4% | 650,000 |  | Unchanged |
| [KURA ONCOLOGY INC (KURA)](/companies/kura.md) | COM | $504.6k | 2.4% | 46,000 |  | Unchanged |
| [VIATRIS INC (VTRS)](/companies/vtrs.md) | COM | $439.9k | 2.1% | 27,700 |  | Unchanged |
| [DYNE THERAPEUTICS INC (DYN)](/companies/dyn.md) | COM | $399.8k | 1.9% | 18,000 |  | Unchanged |
| [BRIDGEBIO PHARMA INC (BBIO)](/companies/bbio.md) | COM | $372.4k | 1.8% | 5,000 |  | Unchanged |
| [EDGEWISE THERAPEUTICS INC (EWTX)](/companies/ewtx.md) | COM | $369.7k | 1.8% | 9,100 |  | Unchanged |
| [PACIRA BIOSCIENCES INC (PCRX)](/companies/pcrx.md) | COM | $342.5k | 1.6% | 13,500 |  | Unchanged |
| [REGENXBIO INC (RGNX)](/companies/rgnx.md) | COM | $318.7k | 1.5% | 26,600 |  | Unchanged |
| [ROCKET PHARMACEUTICALS INC (RCKT)](/companies/rckt.md) | COM | $294.1k | 1.4% | 86,000 |  | Unchanged |
| [JANUX THERAPEUTICS INC (JANX)](/companies/janx.md) | COM | $291.8k | 1.4% | 19,000 |  | Unchanged |
| [MINERALYS THERAPEUTICS INC (MLYS)](/companies/mlys.md) | COM | $283.3k | 1.4% | 10,500 |  | Unchanged |
| GH RESEARCH PLC | ORDINARY SHARES | $274.2k | 1.3% | 10,200 |  | Unchanged |
| [SERES THERAPEUTICS INC (MCRB)](/companies/mcrb.md) | COM NEW | $249.1k | 1.2% | 31,570 |  | Unchanged |
| [AZENTA INC (AZTA)](/companies/azta.md) | COM | $247.5k | 1.2% | 9,700 |  | Unchanged |
| [JASPER THERAPEUTICS INC (JSPR)](/companies/jspr.md) | COM NEW | $195.8k | 0.9% | 465,000 |  | Unchanged |
| [INNOVIVA INC (INVA)](/companies/inva.md) | COM | $186.2k | 0.9% | 8,200 |  | Unchanged |
| [INNATE PHARMA S A (IPHA)](/companies/ipha.md) | SPONSORED ADS | $149.3k | 0.7% | 81,151 |  | Unchanged |
| [ARCUTIS BIOTHERAPEUTICS INC (ARQT)](/companies/arqt.md) | COM | $137.7k | 0.7% | 5,250 |  | Unchanged |
| [SPRUCE BIOSCIENCES INC (SPRB)](/companies/sprb.md) | COM NEW | $54.0k | 0.3% | 1,000 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| CUE BIOPHARMA INC | COM | $0 | 0.0% | 0 |  | Sold out −2,202,854 |

Source: SEC EDGAR, Form 13F-HR, accession 0001013594-26-000908. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.